Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
40.28
+0.68 (1.72%)
Oct 9, 2026, 4:00 PM EDT - Market closed
HRMY Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, HRMY stock has a consensus rating of "Buy" and an average price target of $47.64. The average 1-year stock price forecast is 18.27% higher than the current stock price, while the lowest is $30 (-25.52%) and the highest is $70 (+73.78%).
Price Target: $47.64 (+18.27%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HRMY stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold Maintains $39 → $42 | Hold | Maintains | $39 → $42 | +4.27% | Oct 1, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $51 | Buy | Maintains | $51 | +26.61% | Sep 25, 2026 |
| Needham | Needham | Buy Maintains $50 | Buy | Maintains | $50 | +24.13% | Sep 24, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $60 | Buy | Initiates | $60 | +48.96% | Aug 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $55 | Buy | Reiterates | $55 | +36.54% | Aug 12, 2026 |
Financial Forecast
Revenue This Year
1.03B
from 868.45M
Increased by 18.74%
Revenue Next Year
1.17B
from 1.03B
Increased by 12.98%
EPS This Year
5.22
from 3.60
Increased by 45.05%
EPS Next Year
7.00
from 5.22
Increased by 34.14%
EPS and Forward PE are based on non-GAAP adjusted numbers.